Jennifer Swingle Fogt

Dr. Jennifer Swingle Fogt

College of Optometry, The Ohio State University, Columbus, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
ACAngela M. Chen
Angela M. Chen
SES. Ayse Erzurum
S. Ayse Erzurum
DCDanielle L. Chandler
Danielle L. Chandler
AHAmra Hercinovic
Amra Hercinovic
BMB. Michele Melia
B. Michele Melia
JFJennifer Swingle Fogt
Jennifer Swingle Fogt
Overminus lens therapy is a nonsurgical treatment option for childhood intermittent exotropia (IXT), in which an optical correction with more minus power than the cycloplegic refractive error is worn.1,2 Overminus lenses are typically used as a temporary treatment to improve control of IXT in young children before considering surgery3-7 or orthoptics.4,7 Some authors have reported success in maintaining good control and binocular function after gradually decreasing the strength of the overminus lenses over time and ultimately discontinuing the overminus lenses.5,6

1 December 2020 in Contact Lens and Anterior Eye
Verified
Journal Article
Closed access
MSMuriel Schornack
Muriel Schornack
JFJennifer Swingle Fogt
Jennifer Swingle Fogt
JHJennifer Harthan
Jennifer Harthan
CNCherie B. Nau
Cherie B. Nau
ANAmy Nau
Amy Nau
ESEllen Shorter
Ellen Shorter

1 February 2019 in Contact Lens and Anterior Eye
Verified
Journal Article
Closed access
MSMuriel Schornack
Muriel Schornack
CNCherie Nau
Cherie Nau
ANAmy Nau
Amy Nau
JHJennifer Harthan
Jennifer Harthan
JFJennifer Swingle Fogt
Jennifer Swingle Fogt
ESEllen Shorter
Ellen Shorter

1 November 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
JFJennifer Swingle Fogt
Jennifer Swingle Fogt
MKMatthew J Kowalski
Matthew J Kowalski
PKP. Ewen King-Smith
P. Ewen King-Smith
AEAlice Epitropoulos
Alice Epitropoulos
AHAndrew J Hendershot
Andrew J Hendershot
JBJoseph T Barr
Joseph T Barr
Purpose: The aim of this study was to evaluate the efficacy of a lipid containing emollient eye drop, Soothe XP, which was reformulated in 2014 with a more stable preservative and buffer system, compared to a control, non-emollient, eye drop (Systane Ultra) in improving lipid layer thickness (LLT) in subjects with dry eye due to meibomian gland dysfunction (MGD). Patients and methods: This prospective single-center, open-label, cross-over, examiner masked-study enrolled subjects aged 30–75 years with lipid-deficient dry eye and a clinical diagnosis of MGD as determined by a slit lamp examination, an evaluation of meibomian gland drop out with meibography, and a standard patient evaluation of eye dryness questionnaire of >5. Eligibility was then determined by a LLT of <75 nm at baseline and the inability to increase LLT ≥15 nm with three blinks, as determined by interferometric methods. Subjects were randomized to receive a single emollient or non-emollient eye drop at Visit 1 and were crossed over for the alternate treatment at Visit 2. At each visit, LLT was measured prior to and 15 minutes following the instillation of the assigned eye drop. The primary endpoint was the change in LLT from baseline. Results: Subjects (n=40) were enrolled and 35 completed the two study arms. Mean (±SD) patient age was 55.7 years (10.9) and 69% were female. Mean (±SD) LLT at baseline was 49.5 nm (9.2). Instillation of Soothe XP resulted in an increase in LLT to 77.5 nm (29.3) 15 minutes following drop instillation, which is an increase of 28.0 nm (27.4) (P<0.001). In contrast, LLT 15 minutes after the instillation of Systane Ultra was 50.8 nm (14.1), which was not statistically significant when compared to the baseline LLT. Conclusion: In this study of subjects with MGD, the emollient, or lipid containing eye drop, increased the LLT of tears when measured 15 minutes after instilling a single eye drop.

1 February 2019 in Contact Lens and Anterior Eye
Verified
Journal Article
Closed access
JHJennifer Harthan
Jennifer Harthan
ESEllen Shorter
Ellen Shorter
CNCherie Nau
Cherie Nau
ANAmy Nau
Amy Nau
MSMuriel M. Schornack
Muriel M. Schornack
JFJennifer Swingle Fogt
Jennifer Swingle Fogt

1 September 2020 in Optometry and Vision Science
Verified
Journal Article
Closed access
ESEllen Shorter
Ellen Shorter
MSMuriel Od Schornack
Muriel Od Schornack
JHJennifer Od Harthan
Jennifer Od Harthan
ANAmy Od Nau
Amy Od Nau
JFJennifer Swingle Fogt
Jennifer Swingle Fogt
CNCherie Od Nau
Cherie Od Nau